Autor: |
Valeria Conti, Valentina Manzo, Emanuela De Bellis, Berenice Stefanelli, Carmine Sellitto, Nicola Bertini, Graziamaria Corbi, Nicola Ferrara, Amelia Filippelli |
Přispěvatelé: |
Conti, Valeria, Manzo, Valentina, De Bellis, Emanuela, Stefanelli, Berenice, Sellitto, Carmine, Bertini, Nicola, Corbi, Graziamaria, Ferrara, Nicola, Filippelli, Amelia |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Journal of Personalized Medicine. 12:1578 |
ISSN: |
2075-4426 |
Popis: |
Vitamin K antagonists (VKAs) are used in the prophylaxis and treatment of thromboembolic disorders. Despite a high efficacy, their narrow therapeutic window and high response variability hamper their management. Several patients experience fluctuations in dose–response and are at increased risk of over- or under-anticoagulation. Therefore, it is essential to monitor the prothrombin time/international normalized ratio to determine the so-called stable dose and to adjust the dosage accordingly. Three polymorphisms, CYP2C9∗2, CYP2C9∗3 and VKORC1-1639G>A, are associated with increased sensitivity to VKAs. Other polymorphisms are associated with a request for a higher dose and VKA resistance. We described the clinical cases of two patients who were referred to the Clinical Pharmacology and Pharmacogenetics Unit of the University Hospital of Salerno for pharmacological counseling. One of them showed hypersensitivity and the other one was resistant to VKAs. A systematic review was performed to identify randomized clinical trials investigating the impact of pharmacogenetic testing on increased sensitivity and resistance to VKAs. Although international guidelines are available and information on the genotype-guided dosing approach has been included in VKA drug labels, VKA pharmacogenetic testing is not commonly required. The clinical cases and the results of the systematically reviewed RCTs demonstrate that the pharmacogenetic-based VKA dosing model represents a valuable resource for reducing VKA-associated adverse events. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|